We next showed that serum IFN activity was significantly linked to fever, hematologic disorders (leukopenia), and mucocutaneous manifestations (acute cutaneous lupus and oral ulcer) of EULAR/ACR-2019 criteria domains in treatment-naive SLE patients (Figs. 2 and 3). Here, IFNA1 is linked to systemic lupus erythematosus.